Related Experiment Video
Updated: Mar 2, 2026
Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
Published on: July 5, 2021
Diffuse midline skull base meningiomas: identification of a rare and aggressive subgroup of meningiomas
Matthieu Peyre1,2, Loïc Feuvret3,4, Marc Sanson3,5
1Department of Neurosurgery, Groupe Hospitalier Pitié-Salpêtrière, APHP, 47-83 boulevard de l'Hôpital, Batiment Babinski, 75013, Paris, France. matthieu.peyre@aphp.fr.
Abstract:
Skull base meningiomas may present as clinically aggressive tumors despite being histologically benign. Here we describe a clinico-radiological entity of diffuse midline skull base meningiomas responsible for several neurological morbidities, including hearing and vision loss, intracranial hypertension, secondary hydrocephalus and tonsillar herniation with spinal cord compression. Surgery and radiotherapy were ineffective in stopping the clinical course of those tumors. After targeted sequencing of known mutated genes in meningiomas, we discovered TRAF7 mutations in two out of four tumors, stressing the importance of focusing the research efforts of the meningioma community in understanding the mechanisms underlying TRAF7 related meningioma tumorigenesis.
Insights
Diffuse midline skull base meningiomas are aggressive tumors causing severe neurological issues. TRAF7 mutations were found in some tumors, highlighting a key area for future meningioma research.
Area of Science:
- Neuro-oncology
- Genetics
- Skull Base Surgery
Background:
- Skull base meningiomas, though often benign, can exhibit aggressive clinical behavior.
- Diffuse midline variants pose significant challenges due to their location and impact on neurological function.
Observation:
- This clinico-radiological entity presents with severe neurological morbidities including hearing/vision loss, intracranial hypertension, hydrocephalus, and tonsillar herniation.
- Standard treatments like surgery and radiotherapy showed limited efficacy in halting tumor progression.
Findings:
- Targeted sequencing identified mutations in the TRAF7 gene in two of four analyzed tumors.
- The presence of TRAF7 mutations suggests a potential role in the pathogenesis of these aggressive meningiomas.
Implications:
- Understanding TRAF7-related meningioma tumorigenesis is crucial for developing effective therapeutic strategies.
- Further research into TRAF7 mutations could lead to novel treatment approaches for aggressive skull base meningiomas.
